In this report, we describe 2 previously healthy children who suffered AISs because of acute intracranial LVO within 3 to 4 weeks of COVID-19 infection. We describe 2 previously healthy children who suffered disabling arterial ischemic strokes because of acute intracranial large vessel occlusion within 3 to 4 weeks of coronavirus disease 2019 (COVID-19) infection. Both children presented from communities with high COVID-19 case rates in the Southwest United States. An 8-year-old American Indian girl experienced severe iron deficiency anemia requiring blood transfusion and presented with bilateral middle cerebral artery (MCA) distribution strokes 3 weeks later. She underwent emergent mechanical thrombectomy of the left MCA with successful clot retrieval but experienced reocclusion of that artery 5 hours after intervention. She also had evidence of cerebral arteritis on catheter angiography and vessel wall imaging, and clot pathology revealed recently formed, unorganized platelet- and fibrin-rich thrombus with sparse clusters of erythrocytes, degenerated histiocytes, few eosinophils, and rare neutrophils. A 16-year old African American boy demonstrated evidence of arteritis on brain magnetic resonance angiography and serological markers of cardiac and renal injury accompanied by positive lupus anticoagulant antibodies. The children described in this report express clinical features inconsistent with focal cerebral arteriopathy, including elevated markers of systemic inflammation in both bilateral MCA strokes in one case and multiple organ system dysfunction in the other case. Neither patient fulfilled criteria for multisystem inflammatory syndrome in children, given absence of fever. These cases illustrate that systemic postinfectious arteritis with cerebrovascular involvement may complicate COVID-19 infection in previously healthy school-aged children, and their presentations may overlap but not fulfill criteria for multisystem inflammatory syndrome in children or focal cerebral arteriopathy.
[1]
R. Becker.
COVID-19-associated vasculitis and vasculopathy
,
2020,
Journal of Thrombosis and Thrombolysis.
[2]
J. Mocco,et al.
COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke
,
2020,
American Journal of Neuroradiology.
[3]
A. Radmanesh,et al.
Cerebral Venous Thrombosis Associated with COVID-19
,
2020,
American Journal of Neuroradiology.
[4]
A. Vossough,et al.
Focal Cerebral Arteriopathy in a Pediatric Patient with COVID-19
,
2020,
Radiology.
[5]
D. Alsteens,et al.
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
,
2020,
Nature Communications.
[6]
Thomas J Oxley,et al.
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
,
2020,
The New England journal of medicine.
[7]
J. Sejvar,et al.
Neurological associations of COVID-19
,
2020,
The Lancet Neurology.
[8]
Usman Ali,et al.
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
,
2020,
ACS chemical neuroscience.
[9]
K. Kapur,et al.
A Stroke Alert Protocol Decreases the Time to Diagnosis of Brain Attack Symptoms in a Pediatric Emergency Department.
,
2019,
The Journal of pediatrics.
[10]
W. Heindel,et al.
Impact of Childhood Arterial Ischemic Stroke Standardized Classification and Diagnostic Evaluation Classification on Further Course of Arteriopathy and Recurrence of Childhood Stroke
,
2019,
Stroke.
[11]
M. Wintermark,et al.
Clinical and Imaging Characteristics of Arteriopathy Subtypes in Children with Arterial Ischemic Stroke: Results of the VIPS Study
,
2017,
American Journal of Neuroradiology.
[12]
Lianfeng Zhang,et al.
Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.
,
2007,
Comparative medicine.